Middle East & Africa Flowable Hemostats Market Forecast to 2028 - Regional Analysis - by Material, Product, Application, and End User

The Middle East & Africa flowable hemostats market is expected to grow from US$ 25.10 million in 2022 to US$ 28.45 million by 2028. It is estimated to grow at a CAGR of 2.1% from 2022 to 2028.

Increasing Number of Injuries and Surgical Procedures Fuel Middle East & Africa Flowable Hemostats Market

Injuries are still a significant concern to public health. An increase in global trauma and accident cases is a major driver of the Middle East & Africa flowable hemostats market. According to World Health Organization (WHO), annually approximately 1.3 million people cut short their lives because of a road traffic crash. Between 20 to 50 million people suffer non-fatal injuries, with many incurring a disability because of their injury. Globally, hemorrhage or excessive bleeding is responsible for over one-third of pre-hospital deaths and over 40% of deaths within the first 24 hours. The number of surgeries is rising owing to the increasing musculoskeletal disorders related with sports, occupational injuries, and age-related dysfunction. However, a substantial proportion of health gains are lost owing to sports-related injuries. Concussions are a major cause of mortality and morbidity and are considered the most diffuse brain injuries accountable for inducing mental status alterations. Thus, increasing number of injuries and surgical procedures are responsible for the high adoption of flowable hemostats, thereby driving the market's growth during the forecast period.

Middle East & Africa Flowable Hemostats Market Overview

The Middle East & Africa flowable hemostats market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. The flowable hemostats market in the region is expected to have several growth opportunities owing to the increasing healthcare expenditure, rapid technological advancement, and application in various sectors. Moreover, the surge in the growth in the number of hospitals and surgical centers and the rise in the emerging markets further accelerates the market growth during the forecast period. In Saudi Arabia, rising healthcare spending and well-established hospital and tertiary care centers fuel the growth of the market. The department of Orthopaedic Surgery at King Abdulaziz University Hospital is a clinical unit providing orthopedic care to the public and educational training to students as well as residents in the Saudi Board of Orthopaedic Surgery. The Saudi Ministry of Health (MOH), along with some other government health facilities providers, provides 79% of health services, and private health service providers offer the remaining services. In addition to this, primary health services are provided as the first level of care, covering an extensive network of district-based primary health care providers. General hospitals provide secondary concerns, and specialized hospitals provide tertiary care. The care facilities can be arranged by primary health care clinics in the country. Saudi Arabia is a G20 member that falls under the world's 20 major economies. Saudi's economy accounts for approximately 38% of Middle Eastern gross domestic product (GDP). Over the past half-century, Saudi Arabia has been the third fastest growing economy in the world after China and South Korea. The government has increased healthcare and social affairs expenditure by 48% to US$ 42.64 billion (SR160billion) for the development of new healthcare centers, hospitals, blood banks, and primary care centers. Thus, the rising healthcare expenditure and support from Saudi Arabia's government are expected to offer growth opportunities in the market during the forecast period

Middle East & Africa Flowable Hemostats Market Segmentation

The Middle East & Africa flowable hemostats market is segmented into material, product, application, end user, and country.

Based on material, the Middle East & Africa flowable hemostats market is bifurcated into bovine gelatin & porcine gelatin. The bovine gelatin segment held a larger share of the Middle East & Africa flowable hemostats market in 2022.

In terms of product, the Middle East & Africa flowable hemostats market is segmented into combination hemostats, passive hemostats, and active hemostats. The combination hemostats segment held the largest share of the Middle East & Africa flowable hemostats market in 2022.

Based on application, the Middle East & Africa flowable hemostats market is categorized into general surgery, cardiac surgery, vascular surgery, orthopedic surgery, neuro and spine surgery, and others. The general surgery segment held the largest share of the Middle East & Africa flowable hemostats market in 2022.

Based on end user, the Middle East & Africa flowable hemostats market is segmented into hospitals and clinics, ambulatory surgery centers, and others. The hospitals and clinics segment held the largest share of the Middle East & Africa flowable hemostats market in 2022.

By country, the Middle East & Africa flowable hemostats market is categorized into the Saudi Arabia, South Africa, UAE, the Rest of Middle East & Africa. The Saudi Arabia dominated the Middle East & Africa flowable hemostats market in 2022.

Baxter International Inc, Ethicon (Johnson & Johnson), Pfizer Inc, Teleflex Incorporated, 3-D Matrix Medical Technology, and Aegis Lifesciences are some of the leading companies operating in the Middle East & Africa Middle East & Africa flowable hemostats market.